FDA approves first pill to treat postpartum depression

Postpartum depression is one of the most common complications of childbirth, affecting about a half million Americans each year. It’s among the leading causes of pregnancy-related death. Now, the FDA has approved the first pill for treating postpartum depression. Patricia Kinser, co-chair of perinatal mental health research at VCU’s Institute for Women’s Health, joins John Yang to discuss.